Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
BresMed
h-index: 27
Total citations: 3,103
Total papers: 353
Homepage:
http://www.bresmed.com/
Recent papers from BresMed
Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2024
Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in Japan
Journal of Medical Economics · 2023
Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain
ClinicoEconomics and Outcomes Research · 2023
Matching-Adjusted Indirect Comparisons of Lorlatinib Versus Chemotherapy for Patients With Second-Line or Later Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer
Value in Health · 2022
Cost-effectiveness of a paclitaxel-eluting stent (Eluvia) compared to Zilver PTX for endovascular femoropopliteal intervention
Journal of Medical Economics · 2022
Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis
PLoS ONE · 2022
Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
Infectious Diseases and Therapy · 2022
Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United States
Journal of Medical Economics · 2022
Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece
Journal of health economics and outcomes research · 2022
Quality-adjusted life expectancy norms for the English population
2021
Cost–effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma
Journal of Comparative Effectiveness Research · 2021
Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panel
BMC Neurology · 2021
Varying Willingness to Pay Based on Severity of Illness: Impact on Health Technology Assessment Outcomes of Inpatient and Outpatient Drug Therapies in The Netherlands
Value in Health · 2021
Elucidation of the removal of trivalent and divalent heavy metal ions from aqueous solutions using hybrid-porous composite ion-exchangers by nonlinear regression
Desalination and Water Treatment · 2021
Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi Arabia
PharmacoEconomics - Open · 2021
Patient preferences for stratified medicine in psoriasis: a discrete choice experiment*
British Journal of Dermatology · 2021
Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Infectious Diseases and Therapy · 2021
Cost-Effectiveness of Durvalumab After Chemoradiotherapy in Unresectable Stage III NSCLC: A US Healthcare Perspective
Journal of the National Comprehensive Cancer Network · 2021
Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer
Journal of Medical Economics · 2021
HTA and economics in the United States: a systematic review of ICER reports to evaluate trends, identify factors associated with recommendations, and understand implications
Journal of Managed Care & Specialty Pharmacy · 2020